Page last updated: 2024-12-10

iodothiouracil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Cross-References

ID SourceID
PubMed CID3032445
CHEMBL ID1697840
CHEBI ID135037
SCHEMBL ID1642907
MeSH IDM0111492

Synonyms (28)

Synonym
5-iodo-2-mercaptopyrimidin-4-ol
iodothiouracil
5984-97-4
itrumil
iodothiouracilum [inn-latin]
uracil, 5-iodo-2-thio-
iodotiouracilo [inn-spanish]
iodothiouracil [inn:ban]
5-iodo-2-thiouracil
jodthiouracilum
4(1h)-pyrimidinone, 2,3-dihydro-5-iodo-2-thioxo-
iothiouracil
CHEBI:135037
5-iodo-2-sulfanylidene-1h-pyrimidin-4-one
CHEMBL1697840
AKOS016010823
61o17612t5 ,
unii-61o17612t5
iodotiouracilo
iodothiouracilum
iodothiouracil [inn]
iodothiouracil [who-dd]
SCHEMBL1642907
5-iodo-2-thioxo-2,3-dihydropyrimidin-4(1h)-one
DTXSID1023156
5-iodo-2-thioxo-2,3-dihydro-4(1h)-pyrimidinone, aldrichcpr
Q27263357
SB57937

Research Excerpts

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (2)

ClassDescription
organohalogen compoundA compound containing at least one carbon-halogen bond (where X is a halogen atom).
pyrimidinesAny compound having a pyrimidine as part of its structure.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Bioassays (1)

Assay IDTitleYearJournalArticle
AID588220Literature-mined public compounds from Kruhlak et al phospholipidosis modelling dataset2008Toxicology mechanisms and methods, , Volume: 18, Issue:2-3
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (26)

TimeframeStudies, This Drug (%)All Drugs %
pre-199024 (92.31)18.7374
1990's0 (0.00)18.2507
2000's2 (7.69)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 10.74

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index10.74 (24.57)
Research Supply Index3.40 (2.92)
Research Growth Index4.15 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (10.74)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies1 (3.45%)4.05%
Observational0 (0.00%)0.25%
Other28 (96.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]